FDA

A nanotechnology regulation hat trick from the US federal government

by Andrew Maynard June 10, 2011

It must be Nanotechnology Regulation week in Washington DC.  Yesterday, two federal agencies and the White House released documents that grapple with the effective regulation of products that depend on engineered nanomaterials. In a joint memorandum, the Office of Science and Technology Policy, the Office of Management and Budget and the Office of the United [...]

Read the full article →

Nanotechnology in context – Size matter

by Andrew Maynard November 1, 2007

In July 2007, a specially convened task force of the United States Food and Drug Administration (FDA) concluded that size does in fact matter (FDA 2007).  The focus of the task force was not on the importance of “largeness”, but rather on the technology of the unimaginably small—nanotechnology. Nanotechnology is the technology of manipulating matter [...]

Read the full article →